Camille L. Bedrosian
Overview
Camille L. Bedrosian received an average of $4M in total compensation, including $477K in salary, at Ultragenyx Pharmaceutical between 2018 and 2019.
Source: SEC filings on April 29, 2020 and April 22, 2019.
Related executives
We found nine more executives who work or worked at Ultragenyx Pharmaceutical.
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Officer and Executive Vice President, Translational Sciences
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officer and Executive Vice President
Wladimir Hogenhuis
Ultragenyx Pharmaceutical
Chief Operating Officer
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
Dennis Huang
Ultragenyx Pharmaceutical